Werschler Wm Philip, Weinkle Susan
University of Washington, Seattle, WA, USA.
J Drugs Dermatol. 2005 Jan-Feb;4(1):20-7.
With the growing number of injectable products for soft-tissue augmentation, non-surgical total facial restoration is within reach. Nevertheless, the ideal injectable product has yet to be developed; at present different approaches are required for different soft-tissue deficits. Products have previously been categorized as either temporary (requiring frequent touch-up treatments) or permanent (associated with possible long-term complications and results that do not co-exist harmoniously with the aging face). Although this dichotomy remains, longer-lasting or "semi-permanent" products are beginning to emerge. There has long been a void in the availability of products that can effectively rejuvenate the face for between 2 and 5 years. This time period would allow the patient to correct the continuing signs of aging with re-treatment at intervals that are tolerable from both a financial and time-management perspective.
随着用于软组织填充的可注射产品数量不断增加,非手术全脸修复已触手可及。然而,理想的可注射产品尚未研发出来;目前,针对不同的软组织缺损需要采用不同的方法。以前,产品被分为临时性(需要频繁的补打治疗)或永久性(与可能的长期并发症以及与衰老面部不协调的效果相关)两类。尽管这种二分法仍然存在,但持久或“半永久性”产品开始出现。长期以来,一直缺乏能在2至5年有效使面部年轻化的产品。这段时间将使患者能够从经济和时间管理角度以可承受的间隔重新治疗,从而纠正持续的衰老迹象。